Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Are the costs of screenings and the potential harms of overdiagnosis justified by the number of lives that could be lost to melanoma?
Data between 2005 and 2019 reveal the decline in cervical screenings—and the most common reasons women listed for not receiving them.
The revised 2021 recommendations might not dramatically improve access to screening for minorities.
The update ensures that more minorities and women with lighter smoking histories now qualify for screening.
Nearly a quarter of women met the criteria for counseling based on their personal or family history.
Screenings for colorectal, cervical and breast cancer are commonly given well past the recommended ages.
A recent study analyzed the annual diagnosis rate of metastatic prostate cancer in men 50 and older.
All adults in this age range should be screen for hepatitis C.
Task force recommends BRCA screening for women at increased cancer risk
The U.S. Preventive Services Task Force reaffirmed a 2004 recommendation for those with no symptoms or family history of the disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.